1 / 9

STIKO = Ständige Impfkommission

Decision-making process and impact of implementation of hexavalent vaccines in immunisation programmes: the case of Germany Wolfgang Jilg Institute for Medical Microbiology and Hygiene University of Regensburg, Germany. STIKO = Ständige Impfkommission.

broman
Download Presentation

STIKO = Ständige Impfkommission

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Decision-making process and impact of implementation of hexavalent vaccines in immunisation programmes: the case of Germany Wolfgang Jilg Institute for Medical Microbiology and Hygiene University of Regensburg, Germany

  2. STIKO = Ständige Impfkommission • board of experts appointed by the German Ministry of Health • makes recommendations on vaccination for the German states • recommendations made by the STIKO generally accepted as guidelines • vaccinations recommended by STIKO are usually paid by the insurances

  3. STIKO recommendations and hexa-valent vaccines • no specific recommendation for combined vaccines other than DT or Td • general recommendation, that combined vaccines should be used “.... whenever possible and applicable”

  4. Mu D Me D Pa Mu Ru Me T T D T T T T T Hib D Pa Hib D Pa Hib IPV D Pa D Pa IPV IPV HB Hib HB Hib Combined vaccines for infants available in Germany

  5. Recommendations of STIKO for vaccination of infants and adolescents(STIKO 2001) age vaccines 2 months DTPa Hib IPV HB 3 months DTPa (Hib) (IPV) (HB) 4 months DTPa Hib IPV HB 11-14 months DTPa Hib IPV HB MMR MMR 15-23 months 4- 5 years DT/Td MMR** 9-17 years Td, Pa IPV 3xHB* * when not vaccinated in infancy ** when not vaccinated so far or only once

  6. How are hexavalent vaccines accepted in Germany? • no data available so far • personal impression: pentavalent vaccines plus additional hepatitis B vaccine still preferred, but use of hexavalent vaccine increases slowly

  7. Reasons impeding the implementation of hexavalent vaccines • lack of additional reimbursement for the doctor when using combined vaccines • fear of exhaustion of the immune system (by parents/vaccinees and some doctors!)

  8. What can we do to improve the use of hexavalent vaccines in Germany? • better the situation regarding reimbursement of doctors when using combined vaccines • inform doctors and parents about the advantages and the safety of combined, esp. hexavalent vaccines

More Related